HB 491 -  Access to Appropriate Medications for Serious Mental Illness

by Gonzalez Pittman
Requires AHCA to approve drug products for Medicaid recipients for treatment of serious mental illness without step-therapy prior authorization; directs agency to include rate impact of this act in certain program rates that become effective on specified date.
Effective Date: October 1, 2024
Last Event: Died in Select Committee on Health Innovation on Friday, March 8, 2024 2:25 PM

Related Bills

Staff Analysis

(None Available)

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: H Died in Select Committee on Health Innovation Time: 03/08/2024 - 2:25 PM Member: Committee: Select Committee on Health Innovation Version: __
Event: H 1st Reading Time: 01/09/2024 - 11:31 PM Member: Committee: Version: __
Event: H Now in Select Committee on Health Innovation Time: 11/30/2023 - 4:26 PM Member: Committee: Select Committee on Health Innovation Version: __
Event: H Referred to Health & Human Services Committee Time: 11/30/2023 - 4:26 PM Member: Committee: Health & Human Services Committee Version: __
Event: H Referred to Health Care Appropriations Subcommittee Time: 11/30/2023 - 4:26 PM Member: Committee: Health Care Appropriations Subcommittee Version: __
Event: H Referred to Select Committee on Health Innovation Time: 11/30/2023 - 4:26 PM Member: Committee: Select Committee on Health Innovation Version: __
Event: H Filed Time: 11/16/2023 - 9:15 AM Member: Gonzalez Pittman Committee: Version: __

Statutes Referenced by this Bill

Statute Other Bill Citations
409.901 SB 268, SB 464, HB 653, HB 5301
409.910 SB 268, SB 464, HB 653, HB 5301
409.912 SB 268, SB 2518*, HB 5003

(*) Not the latest version